Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Language
Publication year range
1.
Clinics (Sao Paulo) ; 78: 100208, 2023.
Article in English | MEDLINE | ID: mdl-37148830

ABSTRACT

OBJECTIVE: Oral ulcers are a lesion in the oral mucosa that impacts chewing or drinking. Epoxyeicosatrienoic Acids (EETs) have enhanced angiogenic, regenerative, anti-inflammatory, and analgesic effects. The present study aims to evaluate the effects of 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea (TPPU), a soluble epoxide hydrolase inhibitor for increasing EETs level, on the healing of oral ulcers. METHODS: The chemically-induced oral ulcers were established in Sprague Dawley rats. The ulcer area was treated with TPPU to evaluate the healing time and pain threshold of ulcers. The expression of angiogenesis and cell proliferation-related protein in the ulcer area was detected using immunohistochemical staining. The effects of TPPU on migration and angiogenesis capability were measured with scratch assay and tube formation. RESULTS: Compared with the control group, TPPU promoted wound healing of oral ulcers with a shorter healing time, and raised pain thresholds. Immunohistochemical staining showed that TPPU increased the expression of angiogenesis and cell proliferation-related protein with reduced inflammatory cell infiltration in the ulcer area. TPPU enhanced cell migration and tube-forming potential in vitro. CONCLUSIONS: The present results support the potential of TPPU with multiple biological effects for the treatment of oral ulcers by targeting soluble epoxide hydrolase.


Subject(s)
Oral Ulcer , Rats , Animals , Rats, Sprague-Dawley , Oral Ulcer/drug therapy , Epoxide Hydrolases/metabolism , Ulcer , Eicosanoids , Wound Healing , Phenylurea Compounds/pharmacology , Phenylurea Compounds/therapeutic use
2.
Clin Transl Oncol ; 25(3): 758-767, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36266386

ABSTRACT

PURPOSE: It is well-established that the lack of accurate diagnostic modalities for prostate cancer (PCa) leads to overdiagnosis and overtreatments. Accordingly, this study aimed to assess the value of urine-derived exosomal prostate-specific membrane antigen (PSMA) as a biomarker for the diagnosis of PCa and clinically significant prostate cancer (csPCa). METHODS: A total of 284 urine samples were collected from patients after the digital rectal examination (DRE). Urinary exosomes were extracted using commercial kits, and urine-derived exosomal PSMA was determined via enzyme-linked immunosorbent assay (ELISA). Evaluation of diagnostic accuracy of PSMA was performed via receiver operating characteristic (ROC) analysis, decision curve analysis (DCA), and waterfall plots. RESULTS: We found that urine-derived exosomal PSMA was significantly higher in PCa and csPCa than in benign prostatic hyperplasia (BPH) and BPH + non-aggressive prostate cancer (naPCa) groups (P < 0.001). Furthermore, the urine-derived exosome PSMA yielded area under the ROC curve (AUC) values of 0.876 and 0.826 for detecting PCa and csPCa, respectively, suggesting better performance than traditional clinical biomarkers. Besides, when the cutoff value used corresponded to a sensitivity of 95%, urine-derived exosomal PSMA could avoid unnecessary biopsies in 41.2% of cases and missed only 0.7% of csPCa cases. CONCLUSIONS: Urine-derived exosomal PSMA exhibits a good diagnostic yield for detecting PCa and csPCa. Findings of the present study provide the foothold for future studies on cancer management and research in this patient population.


Subject(s)
Exosomes , Prostatic Hyperplasia , Prostatic Neoplasms , Male , Humans , Prostatic Hyperplasia/pathology , Prostatic Neoplasms/pathology , Biopsy , Biomarkers , Exosomes/pathology , Prostate-Specific Antigen
3.
Clinics ; Clinics;78: 100208, 2023. graf
Article in English | LILACS-Express | LILACS | ID: biblio-1447975

ABSTRACT

Abstract Objective Oral ulcers are a lesion in the oral mucosa that impacts chewing or drinking. Epoxyeicosatrienoic Acids (EETs) have enhanced angiogenic, regenerative, anti-inflammatory, and analgesic effects. The present study aims to evaluate the effects of 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea (TPPU), a soluble epoxide hydrolase inhibitor for increasing EETs level, on the healing of oral ulcers. Methods The chemically-induced oral ulcers were established in Sprague Dawley rats. The ulcer area was treated with TPPU to evaluate the healing time and pain threshold of ulcers. The expression of angiogenesis and cell proliferation-related protein in the ulcer area was detected using immunohistochemical staining. The effects of TPPU on migration and angiogenesis capability were measured with scratch assay and tube formation. Results Compared with the control group, TPPU promoted wound healing of oral ulcers with a shorter healing time, and raised pain thresholds. Immunohistochemical staining showed that TPPU increased the expression of angiogenesis and cell proliferation-related protein with reduced inflammatory cell infiltration in the ulcer area. TPPU enhanced cell migration and tube-forming potential in vitro. Conclusions The present results support the potential of TPPU with multiple biological effects for the treatment of oral ulcers by targeting soluble epoxide hydrolase.

4.
Ann Hepatol ; 27(6): 100745, 2022.
Article in English | MEDLINE | ID: mdl-35964909

ABSTRACT

INTRODUCTION AND OBJECTIVES: Hepatitis B surface antigen (HBsAg) clearance, indicating functional cure or resolved chronic hepatitis B (CHB), remains difficult to achieve via nucleos(t)ide analogue monotherapy. We investigated whether metformin add-on therapy could help achieve this goal in entecavir-treated patients with hepatitis B e antigen (HBeAg)-negative CHB. PATIENTS AND METHODS: Patients with HBeAg-negative CHB who met eligibility criteria (entecavir treatment for > 12 months, HBsAg < 1000 IU/mL) were randomly assigned (1:1) to receive 24 weeks of either metformin (1000 mg, oral, once a day) or placebo (oral, once a day) add-on therapy. The group allocation was blinded for both patients and investigators. Efficacy and safety analyses were based on the intention-to-treat set. The primary outcome, serum HBsAg level (IU/mL) at weeks 24 and 36, was analysed using mixed models. RESULTS: Sixty eligible patients were randomly assigned to the metformin (n = 29) and placebo (n = 31) groups. There was no substantial between-group difference in the HBsAg level at week 24 (adjusted mean difference 0.05, 95% confidence interval -0.04 to 0.13, p = 0.278) or week 36 (0.06, -0.03 to 0.15, p = 0.187), and no significant effect of group-by-time interaction on the HBsAg level throughout the trial (p = 0.814). The occurrence of total adverse events between the two groups was comparable (9 [31.0%] of 29 vs. 5 [16.1%] of 31, p = 0.227) and no patient experienced serious adverse events during the study. CONCLUSION: Although it was safe, metformin add-on therapy did not accelerate HBsAg clearance in entecavir-treated patients with HBeAg-negative CHB.


Subject(s)
Hepatitis B, Chronic , Metformin , Humans , Hepatitis B, Chronic/diagnosis , Hepatitis B, Chronic/drug therapy , Hepatitis B e Antigens , Hepatitis B Surface Antigens , Metformin/adverse effects , Antiviral Agents/adverse effects , DNA, Viral , Hepatitis B virus/genetics , Treatment Outcome
6.
Zoologia (Curitiba, Impr.) ; 32(3): 201-206, May-June 2015. graf
Article in English | VETINDEX | ID: biblio-1504328

ABSTRACT

The activity time of the lesser bamboo bat, Tylonycteris pachypus (Temminck, 1840), was investigated at two observation locations in southern China: Longzhou and Guiping. Two bouts of activity (post dusk and predawn), with an intervening period of night roosting at diurnal roosts, were identified. The period of activity within each bout was usually less than 30 minutes. The activity periods of individuals belonging to the Longzhou population right after dusk and just before dawn lasted longer than those of the the Guiping population. We also found that the nocturnal emergence time of T. pachypus from the Longzhou population happened earlier than in the Guiping population. These findings indicate that the activity time of T. pachypus was quite short at night, and that different locations may affect the nocturnal activity rhythm of this species.


Subject(s)
Animals , Behavior, Animal , Chiroptera
7.
Zoologia (Curitiba) ; 32(3): 201-206, May-June 2015. graf
Article in English | VETINDEX | ID: vti-762311

ABSTRACT

The activity time of the lesser bamboo bat, Tylonycteris pachypus (Temminck, 1840), was investigated at two observation locations in southern China: Longzhou and Guiping. Two bouts of activity (post dusk and predawn), with an intervening period of night roosting at diurnal roosts, were identified. The period of activity within each bout was usually less than 30 minutes. The activity periods of individuals belonging to the Longzhou population right after dusk and just before dawn lasted longer than those of the the Guiping population. We also found that the nocturnal emergence time of T. pachypus from the Longzhou population happened earlier than in the Guiping population. These findings indicate that the activity time of T. pachypus was quite short at night, and that different locations may affect the nocturnal activity rhythm of this species.(AU)


Subject(s)
Animals , Chiroptera , Behavior, Animal
SELECTION OF CITATIONS
SEARCH DETAIL